Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other neoplasm 3

Conditions

Precancerous Conditions 11Neoplasms 4Stomach Neoplasms 3Rare Malignant Neoplasm 3Esophageal Neoplasms 3Colorectal Neoplasms 3Skin Diseases 2Pancreatic Neoplasms 2Obesity-Related Malignant Neoplasm 2Neoplasms by Site 2Neoplasms by Histologic Type 2Keratosis, Actinic 2Carcinoma, Non-Small-Cell Lung 2Venentoclax 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Tongue Neoplasms 1Syndrome 1Stomach Ulcer 1Small Cell Lung Carcinoma 1Secondary Malignant Neoplasm of Liver 1Salivary Gland Neoplasms 1Salivary Gland Malignant Neoplasms 1Rectal Malignant Neoplasms 1Preleukemia 1

Interventions

trametinib 1dabrafenib 1Surgical Procedures, Operative 1Pharmaceutical Preparations 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Rare Malignant Neoplasm × Other neoplasm × Clear all
NCT06119789 2025-03-26

MATRIX-Rare

Oslo University Hospital

Phase 2 Recruiting
96 enrolled
Other neoplasm

Rare Malignant Neoplasm

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting
1,100 enrolled
Other neoplasm

Rare Malignant Neoplasm

NCT05217407 2024-03-22

MASTERKEY ASIA

National Cancer Center, Japan

Recruiting
1,000 enrolled
Other neoplasm

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡